期刊
TRENDS IN PHARMACOLOGICAL SCIENCES
卷 31, 期 5, 页码 199-205出版社
ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tips.2010.01.003
关键词
-
资金
- NASA [NNJ06HE06A]
- NIH [RO1CA128797, R33 CA122864, U54CA143837]
- State of Texas, Emerging Technology Fund
- Department of Defense (DoD)
- [DODW81XWH-09-1-0212]
- [DODW81XWH-07-2-0101]
- NATIONAL CANCER INSTITUTE [R33CA122864, R01CA128797, U54CA143837] Funding Source: NIH RePORTER
Nanomedicine is an emerging field that utilizes nano-technology concepts for advanced therapy and diagnostics. This convergent discipline merges research areas such as chemistry, biology, physics, mathematics and engineering. It therefore bridges the gap between molecular and cellular interactions, and has the potential to revolutionize medicine. This review presents recent developments in nanomedicine research poised to have an important impact on the treatment of cardiovascular disease. This will occur through improvement of the diagnosis and therapy of cardiovascular disorders as atherosclerosis, restenosis and myocardial infarction. Specifically, we discuss the use of nanoparticles for molecular imaging and advanced therapeutics, specially designed drug eluting stents and in vivo/ex vivo early detection techniques.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据